HURP Expression-Assisted Risk Scores Identify Prognosis Distinguishable Subgroups in Early Stage Liver Cancer

por Chang, Ming-Ling, Lin, Shi-Ming, Yeh, Chau-Ting
Publicado 2011

An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection

por Lin, Chih-Lang, Chien, Rong-Nan, Lin, Shi-Ming, Ke, Po-Yuan, Lin, Chen-Chun, Yeh, Chau-Ting
Publicado 2013

Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography

por Huang, Hsin-Chih, Gatchalian, L. B., Hsieh, Yi-Chung, Chen, Wei-Ting, Lin, Chen-Chun, Lin, Shi-Ming
Publicado 2021

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

por Teng, Wei, Jeng, Wen‐Juei, Chen, Wei‐Ting, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming, Sheen, I‐Shyan
Publicado 2022

Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma

por Cheng, Ya-Ting, Jeng, Wen-Juei, Lin, Chen-Chun, Chen, Wei-Ting, Sheen, I-Shyan, Lin, Chun-Yen, Lin, Shi-Ming
Publicado 2016

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience

por Lin, Po‐Ting, Hung, Min‐Hua, Shao, Shih‐Chieh, Chen, Hui‐Yu, Chan, Yuk‐Ying, Chang, Kai‐Cheng, Lin, Shi‐Ming, Ou, Huang‐Tz
Publicado 2023

Durability of Telbivudine-Associated Improvement of Renal Function Following Withdrawal or Switching of Antivirals in Chronic Hepatitis B Patients

por Hsu, Chao-Wei, Chen, Yi-Cheng, Chang, Ming-Ling, Lin, Chen-Chun, Lin, Shi-Ming, Chen, Wei-Ting, Chu, Yu-De, Yeh, Chau-Ting
Publicado 2017

Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study

por Chan, Wen-Hui, Huang, Song-Fong, Lee, Chao-Wei, Wu, Tsung-Han, Pan, Kuan-Tse, Lin, Shi-Ming, Yu, Ming-Chin, Hung, Chien-Fu
Publicado 2019

A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness

por Lin, Shen-Yen, Chen, Chien-Ming, Huang, Bing-Shen, Lai, Ying-Chieh, Pan, Kuang-Tse, Lin, Shi-Ming, Chu, Sung-Yu, Tseng, Jeng-Hwei
Publicado 2021

A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report

por Pan, Xian, Wang, Han-Lu, Lin, Shi-Ming, Lin, Jia-Li, Ruan, Dan-Dan, Zhang, Jian-Hui, Chen, Ting, Luo, Jie-Wei, Fang, Zhu-Ting
Publicado 2022

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

por Hsu, Hsiao-Mei, Tsai, Hsin-I, Lee, Wei-Chen, Wang, Chih-Chi, Yu, Ming-Chin, Lin, Shi-Ming, Lin, Chun-Yen, Wu, Chi-Huan, Lee, Chao-Wei
Publicado 2023

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities

por HUANG, BING-SHEN, TSANG, NGAN-MING, LIN, SHI-MING, LIN, DENG-YN, LIEN, JAU-MIN, LIN, CHEN-CHUN, CHEN, WEI-TING, CHEN, WAN-YU, HONG, JI-HONG
Publicado 2013

Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma

por Hsieh, Ai-Ru, Fann, Cathy SJ, Yeh, Chau-Ting, Lin, Hung-Chun, Wan, Shy-Yi, Chen, Yi-Cheng, Hsu, Chia-Lin, Tai, Jennifer, Lin, Shi-Ming, Tai, Dar-In
Publicado 2017

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis

por Hsieh, Yi-Chung, Jeng, Wen-Juei, Huang, Chien-Hao, Teng, Wei, Chen, Wei-Ting, Chen, Yi-Cheng, Lin, Shi-Ming, Tai, Dar-In, Lin, Chun-Yen, Sheen, I-Shyan
Publicado 2018

Predictors of Mortality Within 6 Weeks After Treatment of Gastric Variceal Bleeding in Cirrhotic Patients

por Teng, Wei, Chen, Wei-Ting, Ho, Yu-Pin, Jeng, Wen-Juei, Huang, Chien-Hao, Chen, Yi-Cheng, Lin, Shi-Ming, Chiu, Cheng-Tang, Lin, Chun-Yen, Sheen, I-Shyan
Publicado 2014

Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma

por Teng, Wei, Jeng, Wen-Juei, Yang, Hwai-I, Chen, Wei-Ting, Hsieh, Yi-Chung, Huang, Chien-Hao, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan
Publicado 2019

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis

por Chang, Ming-Ling, Yeh, Chau-Ting, Chen, Jeng-Chang, Huang, Chau-Chun, Lin, Shi-Ming, Sheen, I-Shyan, Tai, Dar-In, Chu, Chia-Ming, Lin, Wei-Pin, Chang, Ming-Yu, Liang, Chun-Kai, Chiu, Cheng-Tang, Lin, Deng-Yn
Publicado 2008

Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma

por Cheng, Hsiang-Yun, Kang, Pei-Jen, Chuang, Ya-Hui, Wang, Ya-Hui, Jan, Meng-Chin, Wu, Chih-Feng, Lin, Chih-Lin, Liu, Chun-Jen, Liaw, Yun-Fan, Lin, Shi-Ming, Chen, Pei-Jer, Lee, Shou-Dong, Yu, Ming-Whei
Publicado 2014

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

por Su, Chung‐Wei, Teng, Wei, Lin, Po‐Ting, Jeng, Wen‐Juei, Chen, Kuei‐An, Hsieh, Yi‐Chung, Chen, Wei‐Ting, Ho, Ming‐Mo, Hsieh, Chia‐Hsun, Wang, Ching‐Ting, Chai, Pei‐Mei, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming
Publicado 2022

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

por Lin, Shi-Ming, Lu, Sheng-Nan, Chen, Ping-Tsung, Jeng, Long-Bin, Chen, Shinn-Cherng, Hu, Chi-Tan, Yang, Sien-Sing, Le Berre, Marie-Aude, Liu, Xuan, Mitchell, David Y., Prins, Klaas, Grevel, Joachim, Peña, Carol A. E., Meinhardt, Gerold
Publicado 2016